Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.

[1]  T. Müller,et al.  Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. , 2001, The Journal of general virology.

[2]  Z. Xiang,et al.  Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. , 2000, Vaccine.

[3]  L. Babiuk,et al.  Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[4]  D. Tang,et al.  DNA-based non-invasive vaccination onto the skin. , 1999, Vaccine.

[5]  G. Matyas,et al.  Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants , 1999, Infection and Immunity.

[6]  C. Hanlon,et al.  FIRST NORTH AMERICAN FIELD RELEASE OF A VACCINIA-RABIES GLYCOPROTEIN RECOMBINANT VIRUS , 1998, Journal of wildlife diseases.

[7]  Z. Xiang,et al.  Effect of Passive Immunization or Maternally Transferred Immunity on the Antibody Response to a Genetic Vaccine to Rabies Virus , 1998, Journal of Virology.

[8]  D. Tang,et al.  Vaccination onto bare skin , 1997, Nature.

[9]  S. Johnston,et al.  Genetic to genomic vaccination. , 1997, Vaccine.

[10]  Z. Xiang,et al.  The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus , 1997, Journal of virology.

[11]  S. Cryz,et al.  Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults. , 1996, Vaccine.

[12]  Z. Xiang,et al.  A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. , 1996, Virology.

[13]  Fishbein Db,et al.  Rationale and prospects for rabies elimination in developing countries , 1994 .

[14]  M. Kieny,et al.  Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine , 1991, Nature.

[15]  H. Ertl,et al.  Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine. , 1991, Proceedings of the National Academy of Sciences of the United States of America.